IOL Chemicals and Pharmaceuticals Cash Flow
- Market cap
- ₹5,996 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹147.07 – ₹275.76
In the year ended FY25, IOL Chemicals and Pharmaceuticals generated ₹360 crore from operating activities, invested ₹240 crore and paid out ₹89.94 crore on financing activities. Net cash flow for the year was ₹29.98 crore. Free cash flow was ₹150 crore.
IOL Chemicals and Pharmaceuticals cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 360 |
| Cash from investing activities | -240 |
| Cash from financing activities | -89.94 |
| Net cash flow | 29.98 |
| Capital expenditure | 210 |
| Free cash flow | 150 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
IOL Chemicals and Pharmaceuticals cash flow — frequently asked questions
What is IOL Chemicals and Pharmaceuticals' operating cash flow?
IOL Chemicals and Pharmaceuticals' cash flow from operating activities was ₹360 crore in the year ended FY25.
What is IOL Chemicals and Pharmaceuticals' free cash flow?
IOL Chemicals and Pharmaceuticals' free cash flow — operating cash flow minus capital expenditure — was ₹150 crore in FY25, after capital expenditure of ₹210 crore.
How much did IOL Chemicals and Pharmaceuticals spend on investing activities?
Net cash used in investing activities was ₹240 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade IOL Chemicals and Pharmaceuticals With ATS
Track IOLCP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.